# Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)

> **NCT01386177** · PHASE1 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 16 (actual)

## Conditions studied

- Mood Disorder
- Substance-Related Disorders
- Amphetamine-Related Disorders

## Interventions

- **DRUG:** 3,4-Methylenedioxymethamphetamine
- **DRUG:** Doxazosin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01386177
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01386177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01386177, "Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT01386177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*